PTPN11 and myeloproliferative disorder: In human patients, the SHP2-D61G variant is known to be associated with higher predisposition to JMML (-like MPN)) and clinical evidence suggests that JMML pathogenesis is related to prenatal stages of blood ontogeny (Behnert et al., 2021).